Hexa Reports Industry Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Market

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Market
Opportunities and Product Analysis by 2017
“Hodgkin disease is a cancer of the lymphatic system. It usually starts in B
lymphocytes. The disease can spread to nearby lymph nodes. Later it may
spread to the lungs, liver or bone marrow.”
Hodgkin Disease is a cancer of the lymphatic system. It usually starts in B lymphocytes. The disease can spread
to nearby lymph nodes. Later it may spread to the lungs, liver or bone marrow. Signs and symptoms may
include painless swelling of lymph nodes, fatigue, itching, night sweats, rapid weight loss and fever. Risk
factors include age, family history, sex, history of Epstein-Barr infections. Treatment includes chemotherapy,
radiation therapy, immunotherapy and stem cell transplant.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline
Review, H2 2017, provides comprehensive information on the therapeutics under development for Hodgkin
Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology), complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete research and development history and
latest news and press releases.
Browse Detail Report With TOC @ https://www.hexareports.com/report/hodgkin-lymphoma-b-cell-
hodgkin-lymphoma-pipeline-review-h2-2017
Follow Us: